<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">

Paul McGarry


Recent Posts

Champions Oncology Granted Full Accreditation by the AAALAC

Aug 8, 2018 8:30:17 AM / by Paul McGarry

Hackensack, NJ – August 8, 2018 – Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that its new facility in Rockville, MD has been granted Full Accreditation by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) International.  AAALAC commended Champions for the quality and dedication of the staff, the superior quality of the animal facilities, the excellent program of veterinary medical care, and the highly knowledgeable and conscientious Institutional Animal Care and Use Committee.

Read More →

Champions Oncology Reports Record Annual Revenue Exceeding $20M for Fiscal Year Ended April 30, 2018

Jul 27, 2018 9:53:44 AM / by Paul McGarry

Expects Revenue Growth of at Least 20% for Fiscal Year 2019

Hackensack, NJ – July 26, 2018 – Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the fourth fiscal quarter and 12 months ended April 30, 2018.

Read More →

Champions Oncology to Present at the 3rd Annual Disruptive Growth & Healthcare Conference on May 9th

May 3, 2018 9:27:54 AM / by Paul McGarry

HACKENSACK, N.J., - May 3, 2018 - Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that management will be presenting at the 3rd annual Disruptive Growth & Healthcare Conference on Wednesday, May 9th at 8:40am. The conference is being hosted by RHK Capital and ReedSmith LLP, at Reed Smith’s offices located at 599 Lexington Avenue.

Read More →

Champions Oncology Adds Amy Wesa, Ph.D, as Director of Immuno-Oncology Research

May 1, 2018 9:31:57 AM / by Paul McGarry

Experienced Scientist to Lead Immuno-Oncology Research, Driving Significant Expansion of Market Opportunity

Hackensack, NJ – May 1, 2018 – Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that Amy Wesa, Ph.D, has joined the company as Director of Immuno-Oncology Research.

Read More →

Champions Oncology to Present at The MicroCap Conference on April 10th in New York City at the Essex House

Apr 3, 2018 9:34:28 AM / by Paul McGarry

Hackensack, NJ – April 3, 2018 – Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced that management will be presenting at this year’s MicroCap Conference on Tuesday, April 10, 2018 at 9:30am.

Read More →